Jefferies Initiates Coverage On Electra Therapeutics with Buy Rating, Announces Price Target of $32

Jefferies analyst Akash Tewari has initiated coverage on Electra Therapeutics (NASDAQ: ETRA) with a Buy rating. The firm has set a price target of $32 for the company's stock.